Ophthalmics Products



Our ophthalmic portfolio includes below products.

Product Strength
Olopatadine Hcl 0.1 % ophthalmic solution
Olopatadine Hcl 0.2% ophthalmic solution

US: Filed 2 ANDAs, 1 approved, 1 launched commercial, 1 under review

Canada: 2 Filed, 2 approved, 2 Commercial

Emerging Market: 4 Filed, 1 approved, 3 under review

EU/UK: 1 Filed, 1 approved, 1 commercial (4 MAs of ophthalmic products)

For more information about our existing portfolio and our pipeline products please e-mail us at info@usv.in

Disclaimer: Products under patents are offered for sale only in those countries where patents have expired.

© 2024 USV Private Limited. All Rights Reserved.